XCL1 promotes antitumor activity (Chou et al., 2020), and XCL1 expression is also significantly related to the number of tumor infiltrating CD8+T cells as well as the expression of PD-L1 in tumor cells (Tamura and Yoshihara, 2020). The gene discussed is XCL1; the disease is neoplasm.